1792
母义明

    母义明

  • 别名:
  • 外文名:
  • 身高:0cm
  • 星座:
  • 人气:0°
  • 介绍:母义明,男,1962年生,1984年毕业于上海第二军医大学并获学士学位。毕业后在解放军总医院内分泌科从事临床和科研工作,期间分别获解放军军医进修学院医学硕士学位和日本国立九州大学医学博士学位。现担任《中国医学前沿杂志(电子版)》副主编、《中华内分泌代谢杂志》副总编辑、《中华医学杂志〈英文版》特约审稿员、《中国男科学杂志》和《生殖医学杂志》》、《中华糖尿病杂志》、《中国糖尿病杂志》、《实用内科杂志》编委,中华内分泌学会中青年委员。主要研究方向为糖尿病血管病变的发生机制和治疗以及性腺激素的调节机制等。曾获全军科学技术进步奖二等奖一项和三等奖多项以及解放军总医院医疗成果二等奖5项。目前承担的科研工作包括中日科研合作项目一项、国家科技部973重大基础研究项目(由陈香美教授主持〉分课题一项和国家自然科学基金项目一项,并指导下级医师的国家自然科学基金项目三项。己在国际刊物发表论著30篇、国内刊物发表论文150余篇。在英文医学期刊发表论文30余篇。

详细资料

  • 母义明,男,1962年生,1984年毕业于上海第二军医大学并获学士学位。毕业后在解放军总医院内分泌科从事临床和科研工作,期间分别获解放军军医进修学院医学硕士学位和日本国立九州大学医学博士学位。现担任《中国医学前沿杂志(电子版)》副主编、《中华内分泌代谢杂志》副总编辑、《中华医学杂志〈英文版》特约审稿员、《中国男科学杂志》和《生殖医学杂志》》、《中华糖尿病杂志》、《中国糖尿病杂志》、《实用内科杂志》编委,中华内分泌学会中青年委员。主要研究方向为糖尿病血管病变的发生机制和治疗以及性腺激素的调节机制等。曾获全军科学技术进步奖二等奖一项和三等奖多项以及解放军总医院医疗成果二等奖5项。目前承担的科研工作包括中日科研合作项目一项、国家科技部973重大基础研究项目(由陈香美教授主持〉分课题一项和国家自然科学基金项目一项,并指导下级医师的国家自然科学基金项目三项。己在国际刊物发表论著30篇、国内刊物发表论文150余篇。在英文医学期刊发表论文30余篇。

教育经历

1979-1984年上海第二军医大学学士学位;

1989-1991年解放军军医进修学院医学硕士学位;

1997-2001年日本国立九州大学医学部医学博士学位。 

工作经历

毕业后在解放军总医院内分泌科从事临床和科研工作;

1994年晋升副主任医师、副教授;

2001年晋升主任医师、教授和博士生导师;

现任解放军总医院内分泌科主任。[1-2] 

学术任职

中华医学会内分泌学分会第十届委员会主任委员

解放军医学会内分泌专业委员会主任委员

中国医师协会内分泌代谢分会副会长

北京市医学会内分泌学分会主任委员[1-2] 

擅长领域

糖尿病、垂体、甲状腺、甲状旁腺、肾上腺、性腺疾病等。[1-2] 

学术杂志编委

《ChronicDiseasesandTranslationalMedicine》、《中华内分泌代谢杂志》、《实用内科杂志》、《解放军医学杂志》和《中国医学前沿杂志》副主编;

《药品评价杂志》主编。[1-2] 

获奖及荣誉称号

2008年获得全军杰出青年基金;

先后荣立三等功、解放军总医院优秀博士生导师、十佳教师和优秀党支部书记;

2012年和2018年被中华医学会授予杰出贡献奖。  

主要承担科研项目

国家重大科技研究项目3项和国家自然科学基金5项。 

第一或通讯作者SCI文章目录

发表SCI论文200余篇,国内核心期刊发表论文300余篇。主要如下:

1.WangY,WangA,YeY,GaoZ,TangX,YanL,WanQ,WangW,LuoZ,QinQ,ChenLandMuY.ElevatedtriglyceridesratherthanotherlipidparametersareassociatedwithincreasedurinaryalbumintocreatinineratiointhegeneralpopulationofChina:areportfromtheREACTIONstud.CardiovascDiabetol(2019)18:57.https://doi.org/10.1186/s12933-019-0863-8.(通讯作者)

2.GuS,WangA,NingG,ZhangLandMuY.Insulinresistanceisassociatedwithurinaryalbumin-creatinineratioinnormalweightindividualswithhypertensionanddiabetes:theREACTIONstudy.JDiabetes2019Nov26.doi:10.1111/1753-0407.13010.[Epubaheadofprint](通讯作者)

3.YuS,ChengY,ZhangL,YinY,XueJ,LiB,GongZ,GaoJandMuY.Treatmentwithadiposetissue-derivedmesenchymalstemcellsexertsantidiabeticeffects,improveslong-termcomplications,andattenuatesinflammationintype2diabeticrats.StemCellResearch&Therapy(2019)10:333https://doi.org/10.1186/s13287-019-1474-8.(通讯作者)

4.MaoW,JinX,WangH,YeY,ZhangL,GuS,WangJ,NingG,MuY.TheAssociationbetweenRestingHeartRateandUrinaryAlbumin/CreatinineRatioinMiddle-AgedandElderlyChinesePopulation:ACross-SectionalStudy.JDiabetesRes.2019Aug25;2019:9718370.doi:10.1155/2019/9718370.eCollection2019.(通讯作者)

5.GaoY,WangJ,LuoX,SongX,LiuL,KeL,LiaoZ,WangD,MuY,ChenY,EstillJAM.QualityappraisalofclinicalpracticeguidelinesfordiabetesmellituspublishedinChinabetween2007and2017usingtheAGREEIIinstrument.BMJOpen.2019Sep4;9(9):e022392.doi:10.1136/bmjopen-2018-022392.

6.YeY,ZhangL,YanW,WangA,WangW,GaoZ,TangX,YanL,WanQ,LuoZ,QinG,ChenL,WangS,WangY,MuY.Self-reportedsleepdurationanddaytimenappingareassociatedwithrenalhyperfiltrationandmicroalbuminuriainanapparentlyhealthyChinesepopulation.PLoSOne.2019Aug30;14(8):e0214776.doi:10.1371/journal.pone.0214776.eCollection2019.(通讯作者)

7.GaoJ,ChengY,HaoH,YinY,XueJ,ZhangQ,LiL,LiuJ,XieZ,YuS,LiB,HanW,MuY.Decitabineassistsumbilicalcord-derivedmesenchymalstemcellsinimprovingglucosehomeostasisbymodulatingmacrophagepolarizationintype2diabeticmice.StemCellResTher.2019Aug19;10(1):259.doi:10.1186/s13287-019-1338-2.(通讯作者)

8.WangT,LuJ,SuQ,ChenY,BiY,MuY,ChenL,HuR,TangX,YuX,LiM,XuM,XuY,ZhaoZ,YanL,QinG,WanQ,ChenG,DaiM,ZhangD,GaoZ,WangG,ShenF,LuoZ,QinY,ChenL,HuoY,LiQ,YeZ,ZhangY,LiuC,WangY,WuS,YangT,DengH,LiD,LaiS,BloomgardenZT,ShiL,NingG,ZhaoJ,WangW;4CStudyGroup..IdealCardiovascularHealthMetricsandMajorCardiovascularEventsinPatientsWithPrediabetesandDiabetes.JAMACardiol.2019Jul31.doi:10.1001/jamacardio.2019.2499.[Epubaheadofprint]

9.WangJ,ChenK,JinX,LiX,AnP,YangN,ChenY,FangY,MuY.Prognosticfactorsforcesareansectionoutcomeofpregnantwomenwithgestationaldiabetesmellitus:asystematicreviewandmeta-analysis.DiabetesMetabSyndrObes.2019Jun21;12:913-929.doi:10.2147/DMSO.S188293.eCollection2019.(通讯作者)

10.ZangL,HanY,ChenL,HuD,JinH,YangN,ShiX,LiangL,LiuM,FanH,LiQ,MuY.ComparisonoftheEffectivenessandSafetyofVildagliptinAdd-OntoMetforminVersusOtherOralDualAntidiabetesAgentsinPatientswithType2Diabetes:TheChinaProspectiveDiabetesStudy.DiabetesTher.2019Aug;10(4):1391-1405.doi:10.1007/s13300-019-0645-z.Epub2019Jun20.(通讯作者)

11.HuC,MuY,WanQ,QinY,HuR,ShiL,SuQ,YuX,YanL,QinG,TangX,ChenG,GaoZ,WangG,ShenF,LuoZ,ChenL,HuoY,LiQ,YeZ,ZhangY,LiuC,WangY,WuS,YangT,DengH,ChenL,ZhaoJ,LuJ,LinL,LiM,DuR,XuM,XuY,WangT,ZhaoZ,ChenY,LiD,BiY,WangW,NingG;REACTIONStudyGroup.Associationbetweenbirthweightanddiabetes:Roleofbodymassindexandlifestyleinlaterlife.JDiabetes.2019Jun6.doi:10.1111/1753-0407.12960.[Epubaheadofprint](并列第一作者)

12.LuJ,HeJ,LiM,TangX,HuR,ShiL,SuQ,PengK,XuM,XuY,ChenY,YuX,YanL,WangT,ZhaoZ,QinG,WanQ,ChenG,DaiM,ZhangD,GaoZ,WangG,ShenF,LuoZ,QinY,ChenL,HuoY,LiQ,YeZ,ZhangY,DuR,ChengD,LiuC,WangY,WuS,YangT,DengH,LiD,LaiS,BloomgardenZT,ChenL,ZhaoJ,MuY,NingG,WangW,BiY;4CStudyGroup.PredictiveValueofFastingGlucose,PostloadGlucose,andHemoglobinA1conRiskofDiabetesandComplicationsinChineseAdults.DiabetesCare.2019Aug;42(8):1539-1548.doi:10.2337/dc18-1390.Epub2019May31.

13.GuY,GuW,DouJ,LuZ,BaJ,LiJ,WangX,LiuH,YangG,GuoQ,ZangL,ChenK,DuJ,PeiY,MuY.DiagnosticRoleofProstate-SpecificMembraneAntigeninAdrenocorticalCarcinoma.FrontEndocrinol(Lausanne).2019Apr16;10:226.doi:10.3389/fendo.2019.00226.(通讯作者)

14.WangJ,LiY,ChenK,YanW,WangA,WangW,GaoZ,TangX,YanL,WanQ,LuoZ,QinG,ChenL,MuY.AssociationbetweenDurationofExercise(METHoursperWeek)andtheRiskofDecreasedeGFR:ACross-SectionalStudyBasedonaLargeChinesePopulation.JDiabetesRes.2019Mar21;2019:5874603.doi:10.1155/2019/5874603.eCollection2019.(通讯作者)

15.WangJ,ChenK,LiX,JinX,AnP,FangY,MuY.Postoperativeadverseeventsinpatientswithdiabetesundergoingorthopedicandgeneralsurgery.Medicine(Baltimore).2019Apr;98(14):e15089.doi:10.1097/MD.0000000000015089.(通讯作者)

16.JiangJ,CuiJ,WangA,MuY,YanY,LiuF,PanY,LiD,LiW,LiuG,GaisanoHY,DouJ,HeY.AssociationBetweenAgeatNaturalMenopauseandRiskofType2DiabetesinPostmenopausalWomenWithandWithoutObesity.JClinEndocrinolMetab.2019Jul1;104(7):3039-3048.doi:10.1210/jc.2018-02310.

17.WangJ,PeiY,ChenK,YanW,WangA,LiY,LiJ,WangH,AnP,ZhangL,YeY,JinX,NingG,MuY,GuW.AssociationbetweentheNumberofChildbirthsandtheProgressofAtherosclerosisamongWomenwithDiabetes:ACohortStudyBasedonChinesePopulation.IntJEndocrinol.2019Jan27;2019:4874121.doi:10.1155/2019/4874121.eCollection2019.(通讯作者)

18.ZhaoL,PangP,ZangL,LuoY,WangF,YangG,DuJ,WangX,LyuZ,DouJ,MuY.FeaturesandtrendsofthyroidcancerinpatientswiththyroidectomiesinBeijing,Chinabetween1994and2015:aretrospectivestudy.BMJOpen.2019Jan25;9(1):e023334.doi:10.1136/bmjopen-2018-023334.

19.LiJ,LiT,WangH,YanW,MuY.Neutrophil-lymphocyteratioasapredictorofkidneyfunctiondeclineamongindividualswithdiabetesandprediabetes:A3-yearfollow-upstudy.JDiabetes.2019Jun;11(6):427-430.doi:10.1111/1753-0407.12903.Epub2019Feb11.Noabstractavailable.(通讯作者)

20.LiuM,LiX,HaS,WangA,YinS,MuY.AngiotensinType2ReceptorAgonistC21AmelioratestheHigh-FatDiet-InducedPancreaticβ-CellDysfunctionPartiallybyActivationofAntiapoptosisandAutophagy.Pancreas.2019Feb;48(2):250-256.doi:10.1097/MPA.0000000000001241.

21.ZhaoL,YanH,PangP,FanX,JiaX,ZangL,LuoY,WangF,YangG,GuW,DuJ,WangX,LyuZ,DouJ,MuY.Thyroidnodulesizecalculatedusingultrasoundandgrosspathologyaspredictorsofcancer:A23-yearretrospectivestudy.DiagnCytopathol.2019Mar;47(3):187-193.doi:10.1002/dc.24068.Epub2018Nov29.

22.SongX,WangJ,GaoY,YuY,ZhangJ,WangQ,MaX,EstilleJ,JinX,ChenY,MuY.Criticalappraisalandsystematicreviewofguidelinesforperioperativediabetesmanagement:2011-2017.Endocrine.2019Feb;63(2):204-212.doi:10.1007/s12020-018-1786-y.Epub2018Nov16.Review.(通讯作者)

23.PanG,MuY,HouL,LiuJ.Examiningthetherapeuticpotentialofvariousstemcellsourcesfordifferentiationintoinsulin-producingcellstotreatdiabetes.AnnEndocrinol(Paris).2019Feb;80(1):47-53.doi:10.1016/j.ando.2018.06.1084.Epub2018Jul2

24.ZhouX,GongY,TianJ,YangG,LiF,LiL,BaJ,DouJ,MuY.Retrospectiveclinicalanalysisofglucosemetabolisminacromegalypatients.MinervaEndocrinol.2019Jun;44(2):233-235.doi:10.23736/S0391-1977.18.02772-4.Epub2018Jul23.Noabstractavailable.

25.YulongChen.QuanminLi.YingHan.HongmeiJi.MingjunGu.RongwenBian.WeiguangDing.JianCheng.YimingM.VildagliptinVersusa-GlucosidaseInhibitorasAdd-OntoMetforminforType2Diabetes:SubgroupAnalysisoftheChinaProspectiveDiabetesStudy.DiabetesTher2019https://doi.org/10.1007/s13300-019-00742-8(通讯作者)

26.GuY,GuW,DouJ,LvZ,LiJ,ZhangS,YangG,GuoQ,BaJ,ZangL,JinN,DuJ,PeiY,MuY.Bilateraladrenocorticaladenomascausingadrenocorticotropichormone-independentCushing’ssyndrome:Acasereportandreviewoftheliteratur.WorldJClinCases2019April26;7(8):961-971.

27.LiuJ,ZhuD,MuY,XiaW.Managementoffractureriskinpatientswithdiabetes—ChineseExpertConsensus.JournalofDiabetes.2019;1–14.

28.ZangL,HongQ,YangG,GuW,WangA,DouJ,MuY,WuD,LyuZ.MACROD1/LRP16EnhancesLPS-StimulatedInflammatoryResponsesbyUp-RegulatingaRac1-DependentPathwayinAdipocytes.CellPhysiolBiochem.2018;51(6):2591-2603.doi:10.1159/000495931.Epub2018Dec

29.LuJ,WangW,LiM,BiY,XuY,ChenL,ZhaoJ,MuY,DeFronzoRA,NingG.AssociationsofHemoglobinA1cWithCardiovascularDiseaseandMortalityinChineseAdultsWithDiabetes.JAmCollCardiol.2018Dec18;72(24):3224-3225.doi:10.1016/j.jacc.2018.09.062.

30.YinY,HaoH,ChengY,ZangL,LiuJ,GaoJ,XueJ,XieZ,ZhangQ,HanW,MuY.Humanumbilicalcord-derivedmesenchymalstemcellsdirectmacrophagepolarizationtoalleviatepancreaticisletsdysfunctionintype2diabeticmice.CellDeathDis.2018Jul9;9(7):760.doi:10.1038/s41419-018-0801-9.(通讯作者)

31.GuW,GuY,LiJ,YangG,GuoQ,ZangL,DuJ,PeiY,BaJ,LvZ,DouJ,MuY.ACraniopharyngiomaAssociatedWithElevatedCerebrospinalFluidHCGConcentrationsMisdiagnosedasaGerminoma.FrontNeurol.2018Jun14;9:449.doi:10.3389/fneur.2018.00449.eCollection2018.(共同通讯作者)

32.YinY,HaoH,ChengY,GaoJ,LiuJ,XieZ,ZhangQ,ZangL,HanW,MuY.Thehomingofhumanumbilicalcord-derivedmesenchymalstemcellsandthesubsequentmodulationofmacrophagepolarizationintype2diabeticmice.IntImmunopharmacol.2018Jul;60:235-245.doi:10.1016/j.intimp.2018.04.051.Epub2018May25.(共同通讯作者)

33.YinY,YeS,WangH,LiB,WangA,YanW,DouJ,MuY.Redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes.TherClinRiskManag.2018Feb14;14:265-273.doi:10.2147/TCRM.S155753.eCollection2018.(通讯作者)

34.WangG,LiuH,WangC,JiX,GuW,MuY.CinacalcetversusPlaceboforsecondaryhyperparathyroidisminchronickidneydiseasepatients:ameta-analysisofrandomizedcontrolledtrialsandtrialsequentialanalysis.SciRep.2018Feb15;8(1):3111.doi:10.1038/s41598-018-21397-8.(通讯作者)

35.WengJ,ZhouZ,GuoL,ZhuD,JiL,LuoX,MuY,JiaW;T1DChinaStudyGroup.Incidenceoftype1diabetesinChina,2010-13:populationbasedstudy.BMJ.2018Jan3;360:j5295.doi:10.1136/bmj.j5295.

36.PengK,ChenG,LiuC,MuY,YeZ,ShiL,ZhaoJ,ChenL,LiQ,YangT,YanL,WanQ,WuS,WangG,LuoZ,TangX,HuoY,GaoZ,SuQ,WangY,QinG,DengH,YuX,ShenF,ChenL,ZhaoL,XuY,XuM,ChenY,LuJ,LinL,DuR,DaiM,LiM,WangT,ZhaoZ,ZhangD,BiY,LiD,WangW,NingG;REACTIONStudyGroup.Associationbetweensmokingandglycemiccontrolindiabeticpatients:ResultsfromtheRiskEvaluationofcAncersinChinesediabeTicIndividuals:AlONgitudinal(REACTION)study.JDiabetes.2018May;10(5):408-418.doi:10.1111/1753-0407.12625.Epub2018Jan18.

37.ChenK,KangD,YuM,ZhangR,ZhangY,ChenG,MuY.Directhead-to-headcomparisonofglycaemicdurabilityofdipeptidylpeptidase-4inhibitorsandsulphonylureasinpatientswithtype2diabetesmellitus:Ameta-analysisoflong-termrandomizedcontrolledtrials.DiabetesObesMetab.2018Apr;20(4):1029-1033.doi:10.1111/dom.13147.Epub2017Dec5.(通讯作者)

38.LiL,YangG,DouJ,GuW,LvZ,LuJ,MuY.TheRoleofCortisol/ACTHRatioforScreeningofSubclinicalHypercortisolisminPatientswithAdrenalIncidentalomas.ExpClinEndocrinolDiabetes.2018Feb;126(2):71-76.doi:10.1055/s-0043-101236.Epub2017Sep20.

39.MuY,LiuX,LiQ,ChenK,LiuY,LvX,XuX,FanD,ShangN,YangR,PauerL,PanC.EfficacyandsafetyofpregabalinforpainfuldiabeticperipheralneuropathyinapopulationofChinesepatients:Arandomizedplacebo-controlledtrial.JDiabetes.2018Mar;10(3):256-265.doi:10.1111/1753-0407.12585.Epub2017Nov1.(第一作者)

40.ZhaoK,YangS,WangH,ChenK,ZhaoH,MuY.AssociationbetweentheHypertriglyceridemicWaistPhenotypeandPrediabetesinChineseAdultsAged40YearsandOlder.JournalofDiabetesResearchVolume2018,ArticleID1031939,9pageshttps://doi.org/10.1155/2018/1031939(通讯作者)

41.DuJ,LiangL,FangH,XuF,LiW,ShenL,WangX,XuC,BianF,MuY.EfficacyandsafetyofsaxagliptincomparedwithacarboseinChinesepatientswithtype2diabetesmellitusuncontrolledonmetforminmonotherapy:ResultsofaPhaseIVopen-labelrandomizedcontrolledstudy(theSMARTstudy).DiabetesObesMetab.2017Nov;19(11):1513-1520.doi:10.1111/dom.12942.(通讯作者)

42.GuW,LiuY,LiuH,YangG,GuoQ,DuJ,JinN,ZangL,LvZ,BaJ,MuY*andDouJ*.Characteristicsofglucosemetabolismindexesandcontinuousglucosemonitoringsystem(CGMS)inpatientswithinsulinoma.DiabetolMetabSyndr(2017)9:17.DOI10.1186/s13098-017-0215-3.(共同通讯作者)

43.ZangL?,HaoH?,LiuJ,LiY,HanWandMuY*.Mesenchymalstemcelltherapyintype2diabetesmellitus.DiabetolMetabSyndr(2017)9:36.DOI10.1186/s13098-017-0233-1.(通讯作者)

44.GaoF.,ZangL.,WuD.,LiY.J,ZhangQ.,WangH.B.,TianG.L.,MuY.M.PioglitazoneimprovestheabilityoflearningandmemoryviaactivatingERK1/2signalingpathwayinthehippocampusofT2DMrats.NeuroscienceLetters651(2017)165–170.(通讯作者)

45.YuCheng?,JingShen?,WeizhengRen,HaojieHao,ZongyanXie,JiejieLiu,YimingMu*,WeidongHan*.Mildhyperglycemiatriggeredisletfunctionrecoveryinstreptozotocin-inducedinsulin-deficientdiabeticrats.JDiabetesInvestig2017;8:44–55.(通讯作者)

46.Qing-HuaGuo#,Cheng-ZhiWang#,Zhi-QiangWu,YanQin,Bai-YuHan,An-PingWang,Bao-AnWang,Jing-TaoDou,Xiao-ShengWu,*,Yi-MingMu,*Multi-genicpatternfoundinraretypeofhypopituitarism:awhole-exomesequencingstudyofHanChinesewithpituitarystalkinterruptionsyndrome.J.Cell.Mol.Med.VolXX,NoX,2017pp.1-7.(通讯作者)

47.ChenK,KangD,YuM,ZhangR,ZhangY,ChenG,MuY.Directhead-to-headcomparisonofglycemicdurabilityofdipeptidylpeptidase-4inhibitorsandsulphonylureasinpatientswithtype2diabetesmellitus:ameta-analysisoflong-termrandomizedcontrolledtrials.DiabetesObesMetab.2017Nov2.doi:10.1111/dom.13147.(通讯作者)

48.Wei-JunGu,QianZhan,JianZhu,JieLi,Shi-HuiWei,Yi-MingMu.?RituximabwasusedtotreatrecurrentIgG4-relatedhypophysitiswithophthalmopathyastheinitialpresentationAcasereportandliteraturereview.Medicine(2017)96:24.(通讯作者)

49.GuW.LiuY.ChenY.DengW.RanX.ChenL.ZhuD.YangJ.ShinJ.LeeSW,CorderoTL,MuY*.Multicentrerandomizedcontrolledtrialwithsensor-augmentedpumpvsmultipledailyinjectionsinhospitalizedpatientswithtype2diabetesinChina:Timetoreachtargetglucose.Diabetes&Metabolism43(2017)359–363.(通讯作者)

50.XiaoyaSun,HaojieHao,QingwangHan,XiaoyanSong,JiejieLiu,LiangDong,WeidongHan*,YimingMu*.Humanumbilicalcord-derivedmesenchymalstemcellsameliorateinsulinresistancebysuppressingNLRP3inflammasome-mediatedinflammationintype2diabetesrats.StemCellResearch&Therapy(2017)8:241.(通讯作者)

51.YimingMu,ChangyuPan*,BeiFan,UweHehnke,XiuzhenZhang,XuejunZhang,XiaoyueWang,JingdongLiu,YingZhang,JianlingDu,JianhuaMa,YanGong.Efficacyandsafetyoflinagliptin/metforminsingle-pillcombinationasinitialtherapyindrug-na?¨veAsianpatientswithtype2diabetes.DiabetesResearchandClinicalPractice.124(2017):48-56.(第一作者)

52.WangA,LiT,AnP,YanW,ZhengH,WangB,MuY.Exendin-4UpregulatesAdiponectinLevelinAdipocytesviaSirt1/Foxo-1SignalingPathway.PLoSONE.2017Jan25;12(1):e0169469.(通讯作者)

53.ZhangQ,HaoH,XieZ,ChengY,YinY,XieM,HuangH,GaoJ,LiuH,TongC,ZangL,MuY,HanW.M2macrophagesinfusionamelioratesobesityandinsulinresistancebyremodelinginflammatory/macrophages'homeostasisinobesemice.MolCellEndocrinol.2017Mar5;443:63-71.(共同通讯作者)

54.XieM,HaoHJ,ChengY,XieZY,YinYQ,ZhangQ,GaoJQ,LiuHY,MuYM,HanWD.Adipose-derivedmesenchymalstemcellsamelioratehyperglycemiathroughregulatinghepaticglucosemetabolismintype2diabeticrats.BiochemBiophysResCommun.2017Jan29;483(1):435-441.(共同通讯作者)

55.ChengY,ShenJ,RenW,HaoH,XieZ,LiuJ,MuY,HanW.MildhyperglycemiatriggeredisletfunctionrecoveryinSTZ-inducedinsulin-deficientdiabeticrats.JDiabetesInvestig.2017Jan;8(1):44-55.(共同通讯作者)

56.SunQ,ZhengY,ChenK,YanW,LuJ,DouJ,LvZ,WangB,GuW,BaJ,MuY.OsteopeniaisassociatedwithglycemiclevelsandbloodpressureinChinesepostmenopausalwomen:across-sectionalstudy.ClinExpMed.2017Feb;17(1):85-91.(共同通讯作者)

57.WangHB,YanWH,DouJT,LuZH,WangBA,MuYM.AssociationbetweenSelf-reportedSnoringandPrediabetesamongAdultsAged40YearsandOlderwithoutDiabetes.ChinMedJ(Engl).2017Apr5;130(7):791-797.(通讯作者)

58.XuW,MuY,ZhaoJ,ZhuD,JiQ,ZhouZ,YaoB,MaoA,EngelSS,ZhaoB,BiY,ZengL,RanX,LuJ,JiL,YangW,JiaW,WengJ.Efficacyandsafetyofmetforminandsitagliptinbasedtripleantihyperglycemictherapy(STRATEGY):amulticenter,randomized,controlled,non-inferiorityclinicaltrial.SciChinaLifeSci.2017Mar;60(3):225-238.(共同第一和通讯作者)

59.WangCZ,GuoLL,HanBY,SuX,GuoQH,MuYM.PituitaryStalkInterruptionSyndrome:FromClinicalFindingstoPathogenesis.JNeuroendocrinol.2017Jan;29(1).doi:10.1111/jne.12451.Review.(通讯作者)

60.GuanX,MuY,ZhouX,ChenS,DongJ,LiaoL.EfficacyandSafetyofInsulinTherapyinPatientswithType2DiabetesTreatedatDifferentGradesofHospitalsinChina:SubgroupAnalysisoftheReal-WorldSEASStudy.DiabetesTechnolTher.2017Jan;19(1):34-40.

61.MengQ,GeS,YanW,LiR,DouJ,WangH,WangB,MaQ,ZhouY,SongM,YuX,WangH,YangX,LiuF,AlzainMA,YanY,ZhangL,WuL,ZhaoF,HeY,GuoX,ChenF,XuW,GarciaM,MenonD,WangY,MuY,WangW.Screeningforpotentialserum-basedproteomicbiomarkersforhumantype2diabetesmellitususingMALDI-TOFMS.ProteomicsClinAppl.2017Mar;11(3-4).

62.YanHX,PangP,WangFL,TianW,LuoYK,HuangW,YangGQ,JinN,ZangL,DuJ,BaJM,DouJT,MuYM,LyuZH.Dynamicprofileofdifferentiatedthyroidcancerinmaleandfemalepatientswiththyroidectomyduring2000-2013inChina:aretrospectivestudy.SciRep.2017Nov20;7(1):15832.

63.YuF,WeiR,YangJ,LiuJ,YangK,WangH,MuY,HongT.FoxO1inhibitionpromotesdifferentiationofhumanembryonicstemcellsintoinsulinproducingcells.ExpCellRes.2017Nov20.pii:S0014-4827(17)30625-0.doi:10.1016/j.yexcr.2017.11.022.

64.MuYM,GuoLX,LiL,LiYM,XuXJ,LiQM,XuMT,ZhuLY,YuanGY,LiuY,XuC,WangZJ,ShenFX,LuoY,LiuJY,LiQF,WangWH,LaiXY,XuHF,PanCY.Theefficacyandsafetyofinsulindegludecversusinsulinglargineininsulin-naivesubjectswithtype2diabetes:resultsofaChinesecohortfromamultinationalrandomizedcontrolledtrial.ZhonghuaNeiKeZaZhi.2017Sep1;56(9):660-666.(第一作者)

65.WeiQ,ZangL,LiYJ,GuWJ,JinN,GuoQH,DuJ,BaJM,LyuZH,LuJM,DouJT,MuYM,YangGQ.Ananalysisoffourcasesofmisdiagnosedprimarylymphocytichypophysitis.ZhonghuaNeiKeZaZhi.2017Jul1;56(7):512-515.

66.ZangL,LiuY,GengJ,LuoY,BianF,LvX,YangJ,LiuJ,PengY,LiY,SunY,Bosch-TrabergH,MuY.Efficacyandsafetyofliraglutideversussitagliptin,bothincombinationwithmetformin,inChinesepatientswithtype2diabetes:a26-week,open-label,randomised,activecomparatorclinicaltrial.DiabetesObesMetab.2016Apr7.doi:10.1111/dom.12674.[Epubaheadofprint](通讯作者,IF=6.198))

67.SunW,ShiL,YeZ,MuY,LiuC,ZhaoJ,ChenL,LiQ,YangT,YanL,WanQ,WuS,LiuY,WangG,LuoZ,TangX,ChenG,HuoY,GaoZ,SuQ,WangY,QinG,DengH,YuX,ShenF,ChenL,ZhaoL,SunJ,DingL,XuY,XuM,DaiM,WangT,ZhangD,LuJ,BiY,LaiS,LiD,WangW,NingG;REACTIONStudyGroup.Associationbetweenthechangeinbodymassindexfromearlyadulthoodtomidlifeandsubsequenttype2diabetesmellitus.Obesity(SilverSpring).2016Mar;24(3):703-9.doi:10.1002/oby.21336.Epub2016Feb2.

68.LuJ,MuY,SuQ,ShiL,LiuC,ZhaoJ,ChenL,LiQ,YangT,YanL,WanQ,WuS,LiuY,WangG,LuoZ,TangX,ChenG,HuoY,GaoZ,YeZ,WangY,QinG,DengH,YuX,ShenF,ChenL,ZhaoL,SunJ,SunW,WangT,DuR,LinL,DaiM,XuY,XuM,BiY,LaiS,LiD,WangW,NingG;REACTIONStudyGroup.ReducedKidneyFunctionIsAssociatedWithCardiometabolicRiskFactors,PrevalentandPredictedRiskofCardiovascularDiseaseinChineseAdults:ResultsFromtheREACTIONStudy.JAmHeartAssoc.2016Jul22;5(7).pii:e003328.doi:10.1161/JAHA.116.003328.(共同第一作者)

69.SunJ,LuJ,WangW,MuY,ZhaoJ,LiuC,ChenL,ShiL,LiQ,YangT,YanL,WanQ,WuS,LiuY,WangG,LuoZ,TangX,ChenG,HuoY,GaoZ,SuQ,YeZ,WangY,QinG,DengH,YuX,ShenF,ChenL,ZhaoL,BiY,XuM,XuY,DaiM,WangT,ZhangD,LaiS,NingG;REACTIONStudyGroup.PrevalenceofDiabetesandCardiometabolicDisordersinSpousesofDiabeticIndividuals.AmJEpidemiol.2016Sep1;184(5):400-9.doi:10.1093/aje/kwv330.Epub2016Aug16.

70.XieZ,HaoH,TongC,ChengY,LiuJ,PangY,SiY,GuoY,ZangL,MuY,HanW.Humanumbilicalcord-derivedmesenchymalstemcellselicitmacrophagesintoananti-inflammatoryphenotypetoalleviateinsulinresistanceintype2diabeticrats.StemCells.2016Mar;34(3):627-39.共同通讯作者,IF=5.902)

71.ZhaoK,HaoH,LiuJ,TongC,ChengY,XieZ,ZangL,MuY,HanW.Bonemarrow-derivedmesenchymalstemcellsamelioratechronichighglucose-inducedβ-cellinjurythroughmodulationofautophagy.CellDeathandDisease(2015)6,e1885;doi:10.1038/cddis.2015.(共同通讯作者,IF=5.378)

72.ChengY,KangH,ShenJ,HaoH,LiuJ,GuoY,MuY,HanW.Beta-cellregenerationfromvimentin+/MafB+cellsafterSTZ-inducedextremebeta-cellablation.ScientificReports07/2015;5:11703.(共同通讯作者,IF=5.228)

73.SongX,JiaH,JiangY,WangL,ZhangY,MuY,LiuY.Anti-atheroscleroticeffectsoftheglucagon-likepeptide-1(GLP-1)basedtherapiesinpatientswithtype2DiabetesMellitus:Ametaanalysis.ScientificReports2015Jun26;5:10202.(共同通讯作者,IF=5.578)

74.LiuJ,LiuY,WangH,HaoH,HanQ,ShenJ,ShiJ,LiC,MuY,HanW.Directdifferentiationofhepaticstem-likeWBcellsintoinsulin-producingcellsusingsmallmolecules.ScientificReports.2013;3:1185.(共同通讯作者,IF=5.078)

75.ShenJ,ChengY,HanQ,MuY,HanW.Generatinginsulin-producingcellsfordiabetictherapy:existingstrategiesandnewdevelopment.AgeingResRev.2013Mar;12(2):469-78.(共同通讯作者,IF=7.628)

76.Type1diabetescausedbyinterferonalpha-2alphainpolycythemiaveratherapy.DiabetesCare.2010Nov;33(11):e141.(SCI收录,IF:7.851)(通讯作者)

77.YuH,XieLF,ChenK,YangGY,XingXY,ZhaoJJ,HongTP,ShanZY,LiHM,ChenB,TangXL,QiL,YangJ,FangY,LiT,WangSS,LiangX,YinYQ,MuYM.InitiatingCharacteristicsofEarly-onsetType2DiabetesMellitusinChinesePatients.ChinMedJ(Engl).20165thApr;129(7):778-784(通讯作者,IF=1.053)

78.YangG,DouJ,ZhangX,GuW,LvZ,DUJ,BaJ,MuY,LuJ.Increased3b-hydroxysteroiddehydrogenase2and17a-hydroxylaseactivitiesinavirilizedadolescentfemalewithadrenaladenoma:Acasereport.ExpTherMed.2016Feb;11(2):530-534.(通讯作者,IF=1.269)

79.SunQ,ZhengY,ChenK,YanW,LuJ,DouJ,LvZ,WangB,GuW,BaJ,MuY.OsteopeniaisassociatedwithglycemiclevelsandbloodpressureinChinesepostmenopausalwomen:across-sectionalstudy.ClinExpMed.2015Nov29.[Epubaheadofprint](通讯作者,IF=2.959)

80.LiY,MuY,JiQ,HuangQ,KuangH,JiL,YangX.Hypoglycaemia,AbnormalLipids,andCardiovascularDiseaseamongChinesewithType2Diabetes.BiomedResInt.2015;2015:862896.doi:10.1155/2015/862896.Epub2015Oct4.(第二作者,IF=2.134)

81.GuoL,YangG,GuW,JinN,ChenK,DuJ,WangX,OuyangJ,DouJ,BaJ,LvZ,MuY.Short-termefficaciesofintravenousglucocorticoidtherapyformoderate-to-severeGraves'ophthalmopathy.ZhonghuaYiXueZaZhi.2015May26;95(20):1572-5.(通讯作者)

82.LiP,ChenK,NieY,GuoLL,WangHB,WangSS,WangAP,HuDY,MuYM,LiJH;DYSIS-ChinaStudyInvestigators.Associationofobesitywithglucose,bloodpressure,andlipidgoalsattainmentinpatientswithconcomitantdiabetesandhypertension.CurrentMedicalResearchandOpinion.2015,1-9.doi:10.1185/03007995.2015.1058770(通讯作者,IF=2.653)

83.GuS,DengJ,ShiL,MuY,DongH.Cost-effectivenessofsaxagliptinvsglimepirideasasecond-linetherapyaddedtometformininType2diabetesinChina.JournalofMedicalEconomics,2015,18:10,808-820.(第四作者,IF=1.576)

84.ZhengL,YanW,KongY,LiangP,MuY.AnEpidemiologicalStudyofRiskFactorsofThyroidNoduleandGoiterinChineseWomen.Int.J.Environ.Res.PublicHealth2015,12,11608-11620;doi:10.3390/ijerph120911608(通讯作者,IF=1.10)

85.SunQH,ZhengY,ZhangXL,MuYM.RoleofGonadotropin-releasingHormoneStimulationTestinDiagnosingGonadotropinDeficiencyinBothMalesandFemaleswithDelayedPuberty.ChinMedJ(Engl).201520thSep;128(18):2439-2443.(通讯作者,IF=1.053)

86.ZhangLX,GuWJ,LiYJ,WangY,WangWB,WangAP,ShenL,ZangL,YangGQ,LuZH,DouJT,MuYM.PTHIsaPromisingAuxiliaryIndexfortheClinicalDiagnosisofAldosterone-ProducingAdenoma.AmericanJournalofHypertension.AdvanceAccesspublishedAugust24,2015.(通讯作者,IF=2.852)

87.XieLF,OuyangJZ,WangAP,WangWB,LiXT,WangBJ,MuYM.GeneExpressionProfileofPersistentPostoperativeHypertensionPatientswithAldosterone?producingAdenomas.ChineseMedicalJournal,June20,2015,Volume128,Issue12.(通讯作者,IF=1.053)

88.TianY,ChenK,XieZ,FangY,WangH,NieY,HuD,MuY.Theassociationbetweenserumuricacidlevels,metabolicsyndromeandcardiovasculardiseaseinmiddleagedandelderlyChinese:resultsfromtheDYSlipidemiaInternationalStudy.BMCCardiovascularDisorders.12/2015;15(1):66.(通讯作者,IF=1.878)

89.SunX,HaoH,HanW,MuY.Effectsofconditionedmediaforratbonemarrow-derivedmesenchymalstemcellsonpalmiticacid-inducedinsulinresistanceinHepG2cells.ZhonghuaNeiKeZaZhi.2015May;54(5):439-44.Chinese.(通讯作者)

90.YangL,WangA,ZhangY,MuY.12casesofprimarythyroidlymphomainChina.Journalofendocrinologicalinvestigation03/2015;38(7).(通讯作者)

91.WangS,YangL,LiJ,MuY.ConcurrentinsulinomawithmosaicTurnersyndrome:Acasereport.ExpTherMed.2015Mar;9(3):801-804.Epub2015Jan5.(通讯作者)

92.ZhangM,TongG,LiuY,MuY,WengJ,XueY,LuoZ,XueY,ShiL,WuX,SunS,ZhuY,CaoY,ZhangJ,HuangH,NiuB,LiH,GuoQ,GaoY,LiZ,NingG,ZhuD,LiX;HHISStudyGroup.SequentialVersusContinualPurifiedUrinaryFSH/hCGinMenWithIdiopathicHypogonadotropicHypogonadism.JClinEndocrinolMetab.2015Jun;100(6):2449-55.(第四作者)

93.ZhanXR,MuYM,PanCY,XiaoYJ,LuZQ,LiuFH,LiXY,YuJJ.Lifeanddeathofhumanvascularendothelialcellsbystimulationwithfreefattyacidsthroughdeathreceptors.HormMetabRes.2015Feb;47(2):107-13.(第二作者)

94.GuWJ,ZhangQ,WangYQ,YangGQ,HongTP,ZhuDL,YangJK,NingG,JinN,ChenK,ZangL,WangAP,DuJ,WangXL,YangLJ,BaJM,LvZH,DouJT,MuYM.MutationanalysesinpedigreesandsporadiccasesofethnicHanChineseKallmannsyndromepatients.ExperimentalBiologyandMedicine06/2015(通讯作者)

95.GuWJ,YanHX,LuoYK,WangFL,YangGQ,GuoQH,JinN,ZangL,ChenK,DuJ,WangXL,YangLJ,BaJM,DouJT,MuYM,PanCY,LvZH.Characterizationofpapillarythyroidmicrocarcinomasusingsonographicfeaturesinmalignantpapillarythyroidcancer:aretrospectiveanalysis.Medicine(Baltimore).2015May;94(21):e841.doi:10.1097/MD.0000000000000841.

96.ZhengY,WangA,PanC,LuJ,DouJ,LuZ,BaJ,WangB,MuY.ImpactofnightsleepdurationonglycemicandtriglyceridelevelsinChinesewithdifferentglycemicstatus.JDiabetes.2015Jan;7(1):24-30.(通讯作者)[1-3] 

著作译作

主编《解放军总医院临床临床内分泌代谢病学》

主编《解放军总医院内分泌代谢病临床经典病例》

主编《内分泌代谢病临床经典病例-下丘脑垂体专辑》

主编《实用临床内分泌诊疗手册》

主编《胰岛素泵规范治疗教程》

主编《临床药物治疗学内分泌代谢疾病》

主编《高尿酸血症和痛风实用诊疗手册》

主编《国内外糖尿病指南与专家共识解读荟萃》

主编《实时动态胰岛素泵系统(3C疗法)病例集》

主编《内分泌代谢病临床用药及点评》  

科普宣传

在CCTV1、CCTV2、CCTV4和CCTV10,以及北京卫视和江苏卫视等作科普宣传节目150余次;

在央视网、新华网、人民网等网络报刊作科普宣传百余场。 

sitemap